Compound overview · Research
What Is Noopept? GVS-111 Research Overview
What is Noopept? A small proline-containing dipeptide derivative, coded GVS-111 and given the proposed INN omberacetam. This overview covers its chemistry, its relationship to the metabolite cycloprolylglycine, the in-vitro and rodent research behind it, and practical lab handling.
Key takeaways
- Noopept is N-phenylacetyl-L-prolylglycine ethyl ester (GVS-111), C17H22N2O4, about 318.4 g/mol.
- Rat studies identify cycloprolylglycine as a major metabolite, so it is often described as a prodrug.
- In-vitro work reports protection of cultured neurons against oxidative stress.
- It is a dipeptide derivative, not a true racetam, and is not approved by the EMA or FDA.
What is Noopept?
Noopept is the research name for N-phenylacetyl-L-prolylglycine ethyl ester, developmental code GVS-111, proposed INN omberacetam. It was designed at the Zakusov Institute of Pharmacology in Moscow as a dipeptide analogue of piracetam, but structurally it is a modified Pro-Gly dipeptide rather than a racetam (it lacks the 2-oxopyrrolidine ring).
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Structure and specifications
| Property | Value |
|---|---|
| Chemical name | Ethyl 1-(phenylacetyl)-L-prolylglycinate |
| Codes | GVS-111; omberacetam |
| Molecular formula | C17H22N2O4 |
| Molecular weight | ≈318.4 g/mol |
| CAS number | 157115-85-0 |
| Class | N-acyl prolyl-glycine dipeptide ester |
| Main metabolite (rat) | Cyclo-L-prolylglycine |
Noopept and cycloprolylglycine
Studies in rats identified cycloprolylglycine, an endogenous cyclic dipeptide, as a major metabolite of Noopept in brain tissue, which is why Noopept is often described as a prodrug. Cycloprolylglycine has been reported to increase BDNF levels in neuronal cells and to act on AMPA-receptor-dependent pathways in cell models. Ostrovskaya et al. (2001) noted, however, that the parent compound and the metabolite do not behave identically in rat learning paradigms.
Published research findings
In-vitro neuroprotection
In cultured cortical neurons, Pelsman et al. (2003) found that GVS-111 increased neuronal survival after hydrogen-peroxide exposure in a concentration-dependent way and reduced intracellular free radicals and lipid peroxidation, outperforming piracetam and several antioxidants in that model.
Rodent learning models
Rat studies using passive and active avoidance tasks report anti-amnesic activity and effects on one-session learning. Later work examined MAP-kinase signalling and NGF/BDNF gene and protein levels in rat hippocampus.
Handling Noopept in the lab
Noopept is supplied lyophilised (or as a crystalline solid) and is most stable kept dry, sealed and cold. Standard laboratory practice: store long-term at -20 °C, protect from light and moisture, let vials reach room temperature before opening, and prepare solutions fresh in water or ethanol, depending on the assay; it is a small molecule rather than a peptide, so solubility is higher than for most peptides. See our guide to storing peptides in the lab for the full routine, and our COA reading guide for how to check the batch report.
Noopept for research in Europe
Baltic Peptides ships Noopept from Lithuania with tracked delivery across the EU, so orders to Germany, France, the Netherlands, Poland, the Nordics and the Baltics stay inside one customs area. Every batch is tested by Janoshik Analytical before release and published on our COA page. View the Noopept product page for current batches and formats, or see EU shipping for delivery times.
Note that regulatory status varies between EU countries; researchers are responsible for checking local rules before ordering.
Sources and further reading
- Ostrovskaya R.U. et al. (2001). Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration. Bull Exp Biol Med. PubMed
- Pelsman A. et al. (2003). GVS-111 prevents oxidative damage and apoptosis in normal and Down’s syndrome human cortical neurons. Int J Dev Neurosci. PubMed
- N-Phenylacetyl-L-prolylglycine ethyl ester (Wikipedia overview).
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article explains analytical testing and is for educational purposes only.
FAQ
Common questions
What is Noopept?
Is Noopept a racetam?
What is cycloprolylglycine?
What is the molecular weight of Noopept?
Is Noopept legal in every EU country?
Keep reading
Related reading
Noopept
Current batches, formats and the COA for Noopept.
How to read a peptide COA
The 9-step checklist for any certificate of analysis.
How to store peptides in the lab
Storage and handling for lyophilised research compounds.
Research-grade Noopept, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
